Bleeding Control Methods in Open Myomectomy
Effects of Different Intraoperative Bleeding Control Methods on Haematological Outcomes and the Amount of Bleeding in Open Myomectomy: A Prospective Randomized Controlled Study
1 other identifier
interventional
120
1 country
1
Brief Summary
Excessive intraoperative bleeding remains a major challenge during open myomectomy and may lead to postoperative anemia and increased morbidity. Numerous methods have been proposed to minimize hemorrhage; however, evidence regarding their effectiveness in open surgery remains limited. This prospective randomized controlled trial aims to evaluate the effects of tourniquet application, uterine artery bulldog clamping, and no-compression techniques on intraoperative blood loss and postoperative hematological parameters in patients undergoing open myomectomy. A total of 120 patients undergoing open myomectomy will be randomly assigned to three groups: tourniquet group (n = 40), uterine artery bulldog clamp group (n = 40), and no-compression group (n = 40). The primary outcome is intraoperative blood loss. Secondary outcomes include hemoglobin (Hb) and hematocrit (Hct) levels at 24 and 48 hours postoperatively. Myoma volume will be calculated using the spherical formula based on the maximum myoma diameter. Statistical analyses will be performed using one-way analysis of variance (ANOVA) or the Kruskal-Wallis test, as appropriate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedFirst Submitted
Initial submission to the registry
April 15, 2026
CompletedFirst Posted
Study publicly available on registry
April 27, 2026
CompletedApril 27, 2026
April 1, 2026
1 year
April 15, 2026
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative blood loss
Intraoperative blood loss measured in milliliters by calculating the difference between the weight of dry and blood-soaked surgical materials and the volume of blood collected in the suction canister.
During Surgery
Secondary Outcomes (3)
Postoperative hemoglobin level
24 and 48 hours after surgery
Postoperative hematocrit level
24 and 48 hours after surgery
Operative time
During surgery
Study Arms (3)
Tourniquet group
EXPERIMENTALParticipants undergoing open myomectomy in whom an elastic surgical tourniquet was applied at the level of the lower uterine segment/cervix to temporarily reduce uterine blood flow during surgery.
Bulldog clamp group
EXPERIMENTALParticipants undergoing open myomectomy in whom bilateral uterine arteries were dissected and temporarily occluded using bulldog clamps during surgery to control intraoperative bleeding.
No-compression group
NO INTERVENTIONParticipants undergoing open myomectomy without the use of any mechanical or surgical compression technique for uterine arteries; standard surgical procedures were applied.
Interventions
Application of an elastic surgical tourniquet at the level of the lower uterine segment/cervix during open myomectomy to temporarily reduce uterine arterial blood flow. The tourniquet was maintained throughout myoma enucleation and released after completion of uterine repair.
Bilateral uterine arteries were surgically identified and temporarily occluded using bulldog vascular clamps during open myomectomy. The clamps were applied prior to myoma enucleation and removed after uterine repair to restore uterine perfusion.
Eligibility Criteria
You may qualify if:
- Women aged between 18 and 50 years
- Diagnosis of symptomatic uterine leiomyoma
- Planned abdominal (open) myomectomy
- No additional surgical procedure performed during the operation
- Availability of complete preoperative and postoperative laboratory data
You may not qualify if:
- Pregnancy or suspected pregnancy
- Presence of more than 7 myomas
- Suspicion or diagnosis of uterine malignancy
- History of coagulopathy or use of anticoagulant/antiplatelet therapy
- Preoperative blood transfusion
- Concomitant major surgical procedures (e.g., hysterectomy or adnexal surgery)
- History of previous myomectomy
- Incomplete laboratory or clinical data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Van Yüzüncü Yıl University Faculty of Medicine Hospital
Van, Tuşba, 65080, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the surgical interventions, blinding of participants and care providers was not feasible. However, outcome assessors and data analysts were blinded to group allocation.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Professor
Study Record Dates
First Submitted
April 15, 2026
First Posted
April 27, 2026
Study Start
December 15, 2024
Primary Completion
December 15, 2025
Study Completion
December 15, 2025
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to patient confidentiality concerns and the relatively small sample size, which may increase the risk of participant identification. Data may be available from the corresponding author upon reasonable request and with appropriate ethical approval.